KR900005470B1 - 피리딜알킬 나이트 레이트 화합물의 제조방법 - Google Patents
피리딜알킬 나이트 레이트 화합물의 제조방법 Download PDFInfo
- Publication number
- KR900005470B1 KR900005470B1 KR1019830003459A KR830003459A KR900005470B1 KR 900005470 B1 KR900005470 B1 KR 900005470B1 KR 1019830003459 A KR1019830003459 A KR 1019830003459A KR 830003459 A KR830003459 A KR 830003459A KR 900005470 B1 KR900005470 B1 KR 900005470B1
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- compound
- halogen
- hydroxy
- mono
- Prior art date
Links
- 0 C**1C=NC(*)=CC(*)=C1 Chemical compound C**1C=NC(*)=CC(*)=C1 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8221592 | 1982-07-26 | ||
| GB8221592 | 1982-07-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR840005426A KR840005426A (ko) | 1984-11-12 |
| KR900005470B1 true KR900005470B1 (ko) | 1990-07-30 |
Family
ID=10531922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019830003459A KR900005470B1 (ko) | 1982-07-26 | 1983-07-26 | 피리딜알킬 나이트 레이트 화합물의 제조방법 |
Country Status (17)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
| US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 FI FI832490A patent/FI832490L/fi not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES524375A0/es active Granted
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko active IP Right Grant
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES8502088A1 (es) | 1984-12-16 |
| SU1189337A3 (ru) | 1985-10-30 |
| ZA835048B (en) | 1984-03-28 |
| PH18083A (en) | 1985-03-18 |
| DK311683D0 (da) | 1983-07-05 |
| AU1663583A (en) | 1984-02-02 |
| AU565791B2 (en) | 1987-10-01 |
| US4613608A (en) | 1986-09-23 |
| ES524375A0 (es) | 1984-12-16 |
| JPS5951263A (ja) | 1984-03-24 |
| GR78629B (US06291489-20010918-C00045.png) | 1984-09-27 |
| EP0100081B1 (en) | 1989-03-01 |
| ATE40948T1 (de) | 1989-03-15 |
| CA1216850A (en) | 1987-01-20 |
| EP0100081A3 (en) | 1985-05-02 |
| DE3379255D1 (en) | 1989-04-06 |
| NO832700L (no) | 1984-02-06 |
| HU190497B (en) | 1986-09-29 |
| FI832490L (fi) | 1984-01-27 |
| US4540701A (en) | 1985-09-10 |
| FI832490A0 (fi) | 1983-07-07 |
| KR840005426A (ko) | 1984-11-12 |
| JPS6350343B2 (US06291489-20010918-C00045.png) | 1988-10-07 |
| EP0100081A2 (en) | 1984-02-08 |
| DK311683A (da) | 1984-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0283390B1 (fr) | Dérivés du thiazole actifs sur le système cholinergique, procédé d'obtention et compositions pharmaceutiques en contenant | |
| US4166851A (en) | Certain imidazo(1,2a)pyridine derivatives | |
| JPH05112566A (ja) | ピラゾロピリジン化合物およびその製造方法 | |
| CH633266A5 (en) | Process for preparing 1,4-dihydropyridine compounds | |
| US4408047A (en) | Imidazodiazines | |
| KR900005470B1 (ko) | 피리딜알킬 나이트 레이트 화합물의 제조방법 | |
| JPS60156671A (ja) | ジヒドロピリジン誘導体およびその製造法 | |
| US4444775A (en) | Substituted imidazo[1,5-A]pyridines | |
| KR850000626B1 (ko) | 시클로헥센 유도체의 제조방법 | |
| US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
| US4555570A (en) | Substituted 4-alkyl-2-(1H) quinazolinone-1-alkanoic acid derivatives | |
| US4470986A (en) | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors | |
| US3985752A (en) | 6-Methyl-8-(substituted) methylergolines | |
| US4157340A (en) | N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives | |
| US5472973A (en) | Fluorenyl derivatives as anti-inflammatory agents | |
| US4176183A (en) | Novel naphthyridines | |
| US4233301A (en) | Novel imidazoazines and imidazodiazines | |
| GB1598628A (en) | Guanidine derivatives | |
| US4438121A (en) | Isoquinoline amidoxime derivatives | |
| EP0180833B1 (de) | 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel | |
| GB2143814A (en) | Quinazolines | |
| US4330543A (en) | Imidazoazines and imidazodiazines | |
| JP2815691B2 (ja) | Ｋｒｎ２３９１酸付加塩およびその用途 | |
| US4360533A (en) | Glyceryl ester of 1-methyl-2-(3,4-dihydroxyphenyl)alanine | |
| HU191938B (en) | Process for production of new derivatives of 9 and 11 nitro-apovincamin acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| G160 | Decision to publish patent application | ||
| E701 | Decision to grant or registration of patent right | ||
| NORF | Unpaid initial registration fee |